Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Marketing
Market report says 2006 launch of cancer vaccine to prevent human papillomavirus expected
February 27th, 2006
The incorporation of monoclonal antibodies into oncology therapy regimens has created an environment of acceptance toward new biologic therapies, according to a report issued by Research and Markets, Ltd. The report, "Outlook for Cancer Vaccine Development," says developers of cancer vaccines will be able to use this acceptance to establish these treatments as viable therapeutic options. The first major launch of a cancer vaccine, designed to prevent human papillomavirus and, therefore, cervical cancer, is expected in 2006. The regulatory concerns of autologous vaccines and the possibility of marginal efficacy are two factors that will affect the...
Source: Pharma Business Week (2006-02-27)
|
